glp-1 agonist review receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1 receptor agonists for individualized

New research suggests that switching to a maintenance dose of GLP-1 medication could help lock in weight loss.

and in July 2024, the FDA approved Kisunla (donanemab) for early symptomatic Alzheimers, based on evidence of reduced clinical decline and a limitedduration regimen tied to amyloid plaque removal

with a GLP-1

Wear up to 8 hours, then remove and toss

Linhda Nguyen, PA-C, a physician assistant at the Healthy Weight and Wellness Clinic at Nemours Childrens Health in Wilmington, Delaware, said GLP-1 prescriptions for adolescents have increased since the approval of

It is the first GLP-1 pill approved for losing excess weight.